INMB FY 2017 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena

INMBINmune Bio, Inc.

$37M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$981,000

Net Income

-$831,000

EPS (Diluted)

$-0.07

Cash Flow

Operating Cash Flow

-$761,834

Free Cash Flow

-$861,834

Stock-Based Comp.

$199,556

Balance Sheet

Total Assets

$18M

Total Liabilities

$309,717

Stockholders' Equity

$18M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$981,000	-$227,000	-332.2%
Net Income	-$831,000	-$277,000	-200.0%